Back
SPDR® Kensho Clean Power ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
40
CNRG
SPDR® Kensho Clean Power ETF
Last Price:
64.29
Seasonality Move:
6.37%
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
32.71
Seasonality Move:
18.8%
Sell
40
SPDR® Kensho Clean Power ETF (CNRG)
is a Sell
Is SPDR® Kensho Clean Power ETF a Buy, Sell or Hold?
- The current SPDR® Kensho Clean Power ETF [CNRG] share price is $63.93. The Score for CNRG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- CNRG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.72. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CNRG Stock Price Chart
What is SPDR® Kensho Clean Power ETF's stock price today?
-
The SPDR® Kensho Clean Power ETF share price today is $63.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNRG is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNRG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.78 | Buy |
Relative Strength Index (14 RSI): | 59.68 | Buy |
Chaikin Money Flow: | 1474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.09 | Sell |
Relative Strength Index (14 RSI): | 34.53 | Sell |
Chaikin Money Flow: | 2311416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.9 - 40.1) | Sell |
Bollinger Bands (100): | (36.41 - 42.27) | Sell |
CNRG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.15 | Buy |
20-day SMA: | 61.62 | Buy |
50-day SMA: | 61.64 | Buy |
200-day SMA: | 63.41 | Buy |
8-day EMA: | 63.11 | Buy |
20-day EMA: | 61.98 | Buy |
50-day EMA: | 61.76 | Buy |
200-day EMA: | 64.29 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.48 | Sell |
20-day SMA: | 37.67 | Sell |
50-day SMA: | 37.75 | Sell |
200-day SMA: | 49.84 | Sell |
8-day EMA: | 35.24 | Sell |
20-day EMA: | 36.78 | Sell |
50-day EMA: | 38.03 | Sell |
200-day EMA: | 45.57 | Sell |
SPDR® Kensho Clean Power ETF Earnings Growth & CNRG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.32 per share.
SPDR® Kensho Clean Power ETF Technical Analysis
Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |